CompuGroup Medical stock (DE000A288904): Key player in electronic health records market

CompuGroup Medical, a prominent name in health IT, is listed among top participants in the global electronic health records (EHR) market. The sector reached USD 34.96 billion in 2025 and is forecast to hit USD 36.74 billion in 2026, growing to USD 55.34 billion by 2034 at a 5.26% CAGR, Straits Research as of 2026. This positions the company in a vital space for US investors tracking healthcare tech amid rising demand for interoperable patient data systems.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

CompuGroup Medical: core business model

CompuGroup Medical develops and sells software solutions for the healthcare sector, focusing on practice management, electronic health records, and telemedicine tools. The company serves physicians, clinics, pharmacies, and labs globally, with a strong footprint in Europe. Its cloud-based platforms enable secure data exchange, supporting digital transformation in healthcare delivery.

Founded in 1987 and headquartered in Koblenz, Germany, CompuGroup Medical went public in 2000. It emphasizes interoperability standards to connect disparate systems, a critical need as healthcare digitizes. Revenue stems primarily from software licenses, subscriptions, and maintenance services.

Main revenue and product drivers for CompuGroup Medical

Key products include CGM Clinical, a suite for outpatient practices, and CGM M, tailored for hospitals. These drive recurring SaaS revenue, bolstered by integrations with national health systems. In 2025 market data, CompuGroup Medical is noted alongside Epic Systems and Oracle Health in EHR leadership, Straits Research as of 2026.

Hospital end-use led with 52.94% share in 2025, where CompuGroup's solutions excel in patient administration and diagnostics. North America's dominance (42.31% share) highlights US exposure via partnerships and exports, relevant for American investors eyeing international health tech.

Industry trends and competitive position

The EHR market's 5.26% CAGR to 2034 reflects regulatory pushes like US interoperability rules under ONC and HIPAA. Asia Pacific grows fastest, but North America remains pivotal. CompuGroup Medical competes with US giants like Epic and Cerner (now Oracle), differentiating via European regulatory expertise and cost-effective modular software.

Trends include AI integration for predictive analytics and blockchain for data security. CompuGroup invests in these, positioning for growth in telehealth post-pandemic.

Why CompuGroup Medical matters for US investors

Listed on Frankfurt (DE000A288904), CompuGroup Medical offers US investors access to Europe's health IT consolidation via ADRs or direct trading. Its role in EHR underscores exposure to US market trends, where hospitals adopt digital records to cut costs and improve outcomes. North America's 42%+ EHR share amplifies relevance.

Conclusion

CompuGroup Medical operates at the intersection of health IT and digital transformation, with recognition in the expanding EHR market. Its European base complements US sector growth, offering diversified exposure. Investors monitor software adoption and regulatory shifts for ongoing developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.